FSS Earnings

FSS reported its earnings on 2026-02-25, showcasing a revenue of against an estimate of 564.35M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 1.08 by 0%. The stock experienced a 2.08% price change on the earnings day and a 2.21% change over the next five days, reflecting market reactions to the results.

Following FSS's earnings announcement on 2026-02-25, the stock price moved by 2.08% on the day of the release. Over the subsequent five days, it saw a 2.21% change. Historically, FSS's stock price tends to shift by an average of 0.11% in the 10 days leading up to earnings and 2.97% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate FSS's annual revenue to reach 556.17M, while the EPS is projected at 0.91. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between FSS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, FSS's stock price typically moves by 0.11% in the 10 days before its earnings and 2.97% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.91 and revenue of 556.17M.

The earnings call summary and Q&A provide a generally positive outlook. Financial performance shows raised guidance for EPS and net sales, indicating confidence in future growth. Product development and market strategy are robust, with acquisitions and organic growth contributing significantly. Despite some uncertainties in management's responses, the overall sentiment is optimistic, with strong demand, expanded capacity, and strategic M&A plans. The shareholder return plan and financial health appear stable, with no major negative indicators. This suggests a positive stock price movement over the next two weeks.